In addition, FBP1 expression in BLBC cells inhibited tumorigenicity in vitro and suppressed tumor formation in vivo, indicating that the loss of FBP1 is a critical oncogenic alteration in BLBC [146]. The gene discussed is FBP1; the disease is neoplasm.